UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

The European respiratory journal, 2010-09, Vol.36 (3), p.531-539

2010

Volltextzugriff (PDF)

Asthma–COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?

Allergy (Copenhagen), 2017-01, Vol.72 (1), p.137-145

2017

Volltextzugriff (PDF)

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.1819-1824

2017

Volltextzugriff (PDF)

Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1275-1284

2021

Volltextzugriff (PDF)

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.1399-1410

2019

Volltextzugriff (PDF)

WS12.3 Prognostic value of the 6 minute walk test in adults with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S24-S24

2013

Volltextzugriff (PDF)

WS12.4 Determinants of 6 minute walking distance and desaturation during the 6 minute walk test in adults with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S24-S24

2013

Volltextzugriff (PDF)

Early detection of COPD in occupational medicine in the Alpes-Maritimes

Revue des maladies respiratoires, 2015-01, Vol.32 (1), p.30

2015

Volltextzugriff (PDF)

P210 Safety and effectiveness of lumacaftor-ivacaftor in cystic fibrosis patients with ppFEV1 ≤40% or ≥90

Journal of cystic fibrosis, 2020-06, Vol.19, p.S116-S116

2020

Volltextzugriff (PDF)

P208 Multidimensional assessment of response to lumacaftor-ivacaftor in cystic fibrosis patients homozygous for the F508del mutation

Journal of cystic fibrosis, 2020-06, Vol.19, p.S115-S115

2020

Volltextzugriff (PDF)

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

The European respiratory journal, 2014-04, Vol.43 (4), p.1201-1203

2014

Volltextzugriff (PDF)

Phenotypes Influencing Low Physical Activity in Maintenance Dialysis

Journal of renal nutrition, 2015-01, Vol.25 (1), p.31-39

2015

Volltextzugriff (PDF)

D35 IT'S ALL TOO MUCH: COPD COMORBIDITIES: Low Mortality Rates In Obese COPD Patients Despite High Rates Of Diagnosed Comorbidities

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (1663-1672), p.1663-1672

2015

Volltextzugriff (PDF)

Characterization of seawater samples using chemometric methods applied to biomarker fatty acids

Organic geochemistry, 1988, Vol.12 (3), p.281-288

1988

Volltextzugriff (PDF)

C22 COPD PHENOTYPES: Various Thresholds Of Blood Eosinophil Levels (eos) Do Not Identify A Specific Clinical COPD Phenotype

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Impact of current cough on health-related quality of life in patients with COPD

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.2091-2097

2016

Volltextzugriff (PDF)

Un algorithme pour l’identification des phénotypes de BPCO en pratique clinique quotidienne

Revue des maladies respiratoires, 2017-01, Vol.34, p.A7-A7

2017

Volltextzugriff (PDF)

Le taux d’éosinophiles sanguins permet-il d’identifier un phénotype spécifique de BPCO ?

Revue des maladies respiratoires, 2017-01, Vol.34, p.A3-A3

2017

Volltextzugriff (PDF)

DIALYSIS GENERAL

Nephrology, dialysis, transplantation, 2014-05, Vol.29 (suppl 3), p.iii32-iii33

2014

Volltextzugriff (PDF)

Évolution des traitements de fond entre 2001 et 2012 chez les patients atteints de BPCO en France. Impact de la mise à disposition des anticholinergiques de longue durée d’action

Revue des maladies respiratoires, 2017-05, Vol.34 (5), p.535-543

2017

Volltextzugriff (PDF)

Asthma-COPD overlap syndrome (ACOS) et BPCO « pure » : quelles différences ?

Revue française d'allergologie (2009), 2016-04, Vol.56 (3), p.317-318

2016

Volltextzugriff (PDF)

Détection précoce de la BPCO en milieu professionnel dans les Alpes-Maritimes

Revue des maladies respiratoires, 2015-01, Vol.32 (1), p.30-37

2015

Volltextzugriff (PDF)

La toux contribue de façon indépendante à l’altération de la qualité de vie au cours de la BPCO

Revue des maladies respiratoires, 2015-01, Vol.32, p.A40-A40

2015

Volltextzugriff (PDF)

Identification de 2 phénotypes à haut risque mortalité chez les patients BPCO

Revue des maladies respiratoires, 2012, Vol.29, p.A10-A10

2012

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(32)

Sprache

Englisch
(18)
Französisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(12)
Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Female
(10)
Male
(10)
Middle Aged
(10)
Aged
(9)
Life Sciences
(9)
Chronic Obstructive Pulmonary Disease
(8)
Comorbidity
(8)
Respiratory System
(8)
Pulmonary Disease, Chronic Obstructive - Diagnosis
(7)
Quality Of Life
(7)
Spirometry
(7)
France
(6)
Risk Factors
(6)
Body Mass Index
(5)
Copd
(5)
Dyspnea
(5)
Original Research
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

Asthma–COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities

WS12.3 Prognostic value of the 6 minute walk test in adults with cystic fibrosis

WS12.4 Determinants of 6 minute walking distance and desaturation during the 6 minute walk test in adults with cystic fibrosis

Early detection of COPD in occupational medicine in the Alpes-Maritimes

P210 Safety and effectiveness of lumacaftor-ivacaftor in cystic fibrosis patients with ppFEV1 ≤40% or ≥90

P208 Multidimensional assessment of response to lumacaftor-ivacaftor in cystic fibrosis patients homozygous for the F508del mutation

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

Phenotypes Influencing Low Physical Activity in Maintenance Dialysis

D35 IT'S ALL TOO MUCH: COPD COMORBIDITIES: Low Mortality Rates In Obese COPD Patients Despite High Rates Of Diagnosed Comorbidities

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease

Characterization of seawater samples using chemometric methods applied to biomarker fatty acids

C22 COPD PHENOTYPES: Various Thresholds Of Blood Eosinophil Levels (eos) Do Not Identify A Specific Clinical COPD Phenotype

Impact of current cough on health-related quality of life in patients with COPD

Un algorithme pour l’identification des phénotypes de BPCO en pratique clinique quotidienne

Le taux d’éosinophiles sanguins permet-il d’identifier un phénotype spécifique de BPCO ?

DIALYSIS GENERAL

Évolution des traitements de fond entre 2001 et 2012 chez les patients atteints de BPCO en France. Impact de la mise à disposition des anticholinergiques de longue durée d’action

Asthma-COPD overlap syndrome (ACOS) et BPCO « pure » : quelles différences ?

Détection précoce de la BPCO en milieu professionnel dans les Alpes-Maritimes

La toux contribue de façon indépendante à l’altération de la qualité de vie au cours de la BPCO

Identification de 2 phénotypes à haut risque mortalité chez les patients BPCO

Suchergebnisse filtern